Sun Pharma Advanced Research Company (SPARC) has target of Rs 86.25, says Ashish Tater of Fort Share Broking.
Tater told CNBC-TV18, "Sun Pharma Advanced Research Company is a stock which might bore investors in the short span but is a true multibagger if any of its delivery systems NDDS or NCE hits, if any of the blockbuster drugs if it
Discover the latest Business News, Sensex, and Nifty updates. Obtain Personal Finance insights, tax queries, and expert opinions on Moneycontrol or download the Moneycontrol App to stay updated!
